These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


392 related items for PubMed ID: 19878974

  • 1. Systemic sclerosis: bilateral improvement of Raynaud's phenomenon with unilateral digital sympathectomy.
    Wasserman A, Brahn E.
    Semin Arthritis Rheum; 2010 Oct; 40(2):137-46. PubMed ID: 19878974
    [Abstract] [Full Text] [Related]

  • 2. Ulnar artery involvement in systemic sclerosis (scleroderma).
    Taylor MH, McFadden JA, Bolster MB, Silver RM.
    J Rheumatol; 2002 Jan; 29(1):102-6. PubMed ID: 11824945
    [Abstract] [Full Text] [Related]

  • 3. [Sclerodermic acrosyndromes].
    Carpentier PH.
    Rev Prat; 2002 Nov 01; 52(17):1891-5. PubMed ID: 12532865
    [Abstract] [Full Text] [Related]

  • 4. Statins: potentially useful in therapy of systemic sclerosis-related Raynaud's phenomenon and digital ulcers.
    Abou-Raya A, Abou-Raya S, Helmii M.
    J Rheumatol; 2008 Sep 01; 35(9):1801-8. PubMed ID: 18709692
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Digital sympathectomy for refractory Raynaud's phenomenon in an adolescent.
    Drake DB, Kesler RW, Morgan RF.
    J Rheumatol; 1992 Aug 01; 19(8):1286-8. PubMed ID: 1383543
    [Abstract] [Full Text] [Related]

  • 9. Intravenous iloprost treatment of Raynaud's phenomenon and ischemic ulcers secondary to systemic sclerosis.
    Wigley FM, Seibold JR, Wise RA, McCloskey DA, Dole WP.
    J Rheumatol; 1992 Sep 01; 19(9):1407-14. PubMed ID: 1279170
    [Abstract] [Full Text] [Related]

  • 10. The use of digital artery sympathectomy as a salvage procedure for severe ischemia of Raynaud's disease and phenomenon.
    McCall TE, Petersen DP, Wong LB.
    J Hand Surg Am; 1999 Jan 01; 24(1):173-7. PubMed ID: 10048533
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon.
    Merkel PA, Herlyn K, Martin RW, Anderson JJ, Mayes MD, Bell P, Korn JH, Simms RW, Csuka ME, Medsger TA, Rothfield NF, Ellman MH, Collier DH, Weinstein A, Furst DE, Jiménez SA, White B, Seibold JR, Wigley FM, Scleroderma Clinical Trials Consortium.
    Arthritis Rheum; 2002 Sep 01; 46(9):2410-20. PubMed ID: 12355489
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of clonazepam on Raynaud's phenomenon and fingertip ulcers in scleroderma.
    Colakoğlu M, Cobankara V, Akpolat T.
    Ann Pharmacother; 2007 Sep 01; 41(9):1544-7. PubMed ID: 17666574
    [Abstract] [Full Text] [Related]

  • 17. Effect of ketanserin on Raynaud's phenomenon in progressive systemic sclerosis: a double-blind trial.
    Lukác J, Rovenský J, Tauchmannová H, Zitnan D.
    Drugs Exp Clin Res; 1985 Sep 01; 11(9):659-63. PubMed ID: 3916837
    [Abstract] [Full Text] [Related]

  • 18. Use of biofeedback training in treatment of Raynaud's disease and phenomenon.
    Yocum DE, Hodes R, Sundstrom WR, Cleeland CS.
    J Rheumatol; 1985 Feb 01; 12(1):90-3. PubMed ID: 3981523
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Increased circulating platelet-leucocyte complexes in patients with primary Raynaud's phenomenon and Raynaud's phenomenon secondary to systemic sclerosis: a comparative study.
    Pamuk GE, Turgut B, Pamuk ON, Vural O, Demir M, Cakir N.
    Blood Coagul Fibrinolysis; 2007 Jun 01; 18(4):297-302. PubMed ID: 17473568
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 20.